Mylan Faces Scrutiny Over EpiPen Price Increases

Mylan became the latest pharmaceutical company to face outrage about higher drug costs after the company’s substantial price increases for the EpiPen emergency allergy treatment.

from WSJ.com: US Business http://ift.tt/2bjskat
via IFTTT